P. Elsakov Et Al. , "Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers," HEREDITARY CANCER IN CLINICAL PRACTICE , vol.5, no.3, pp.119-143, 2007
Elsakov, P. Et Al. 2007. Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers. HEREDITARY CANCER IN CLINICAL PRACTICE , vol.5, no.3 , 119-143.
Elsakov, P., Foretova, L., Goetz, P., de Groot, J. W. B., van der Graaf, W. T. A., GÜLER, G., ... Huebner, K.(2007). Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers. HEREDITARY CANCER IN CLINICAL PRACTICE , vol.5, no.3, 119-143.
Elsakov, Pavel Et Al. "Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers," HEREDITARY CANCER IN CLINICAL PRACTICE , vol.5, no.3, 119-143, 2007
Elsakov, Pavel Et Al. "Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers." HEREDITARY CANCER IN CLINICAL PRACTICE , vol.5, no.3, pp.119-143, 2007
Elsakov, P. Et Al. (2007) . "Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers." HEREDITARY CANCER IN CLINICAL PRACTICE , vol.5, no.3, pp.119-143.
@article{article, author={Pavel Elsakov Et Al. }, title={Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers}, journal={HEREDITARY CANCER IN CLINICAL PRACTICE}, year=2007, pages={119-143} }